IDXX

545.86

2.91% -16.34

Handel nachbörslich: 545.31 -0.55 -0.10%

Idexx Laboratories Inc (IDXX)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt IDXX? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$562.20

Offen:

$562.05

24-Stunden-Volumen:

585.00K

Relative Volume:

0.91

Marktkapitalisierung:

$43.00B

Einnahmen:

$4.45B

Nettoeinkommen (Verlust:

$1.10B

KGV:

40.16

EPS:

13.591

Netto-Cashflow:

$1.06B

1W Leistung:

-3.72%

1M Leistung:

-3.18%

6M Leistung:

-14.13%

1J Leistung:

-14.69%

1-Tages-Spanne:

$543.60

$563.13

1-Wochen-Bereich:

$538.20

$575.56

52-Wochen-Spanne:

$518.55

$769.98

Idexx Laboratories Inc Stock (IDXX) Company Profile

Firmenname

Idexx Laboratories Inc

Sektor

Healthcare (1077)

Branche

Diagnostics & Research (50)

Telefon

(207) 556-0300

Adresse

ONE IDEXX DRIVE, WESTBROOK, ME

Mitarbeiter

11,000

Twitter

@idexx

Nächster Verdiensttermin

2026-08-04

Neueste SEC-Einreichungen

IDXX's Discussions on Twitter

Compare IDXX vs TMO, DHR, NTRA, A

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
IDXX Idexx Laboratories Inc	545.86	44.29B	4.45B	1.10B	1.06B	13.59
TMO Thermo Fisher Scientific Inc	627.55	226.85B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	215.91	148.68B	24.78B	3.68B	5.29B	5.1743
NTRA Natera Inc	324.84	46.86B	2.50B	-226.32M	71.51M	-1.6412
A Agilent Technologies Inc	156.30	43.89B	7.23B	1.41B	1.09B	4.979

Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-04-15	Eingeleitet	Citigroup	Neutral
2025-12-09	Eingeleitet	Barclays	Overweight
2025-10-31	Hochstufung	Stifel	Hold → Buy
2025-10-01	Eingeleitet	UBS	Neutral
2025-08-05	Bestätigt	BTIG Research	Buy
2025-07-01	Eingeleitet	Jefferies	Buy
2024-12-02	Eingeleitet	Leerink Partners	Outperform
2024-07-25	Eingeleitet	BTIG Research	Buy
2024-01-30	Herabstufung	Piper Sandler	Overweight → Neutral
2023-12-07	Eingeleitet	Exane BNP Paribas	Outperform
2023-12-04	Hochstufung	Cleveland Research	Neutral → Buy
2023-08-02	Herabstufung	Atlantic Equities	Overweight → Neutral
2022-07-25	Herabstufung	Stifel	Buy → Hold
2022-07-21	Hochstufung	Goldman	Neutral → Buy
2022-07-12	Eingeleitet	Piper Sandler	Overweight
2022-05-05	Herabstufung	BofA Securities	Buy → Neutral
2022-02-08	Eingeleitet	Atlantic Equities	Overweight
2021-11-18	Eingeleitet	Morgan Stanley	Overweight
2021-08-05	Fortgesetzt	Credit Suisse	Outperform
2021-07-12	Herabstufung	Guggenheim	Buy → Neutral
2021-02-17	Eingeleitet	Barclays	Overweight
2019-09-09	Eingeleitet	Goldman	Neutral
2019-05-23	Eingeleitet	Guggenheim	Buy
2018-11-02	Bestätigt	BofA/Merrill	Buy
2018-05-07	Bestätigt	Stifel	Buy
2018-01-16	Eingeleitet	Piper Jaffray	Overweight
2017-08-23	Hochstufung	BofA/Merrill	Neutral → Buy
2017-07-28	Hochstufung	CL King	Neutral → Buy
2017-02-03	Herabstufung	Feltl & Co.	Hold → Sell
2016-09-29	Fortgesetzt	BofA/Merrill	Neutral
2016-08-16	Bestätigt	Stifel	Buy
2016-08-03	Hochstufung	Northcoast	Sell → Neutral
2016-07-20	Bestätigt	Canaccord Genuity	Buy
2016-04-19	Bestätigt	Canaccord Genuity	Buy
2016-04-01	Eingeleitet	CL King	Neutral
2016-03-21	Bestätigt	Stifel	Buy
2016-02-04	Eingeleitet	Credit Suisse	Outperform
2015-10-29	Bestätigt	Stifel	Buy
2015-08-28	Herabstufung	Raymond James	Outperform → Mkt Perform
2015-08-13	Bestätigt	Stifel	Buy
2015-07-23	Bestätigt	Canaccord Genuity	Buy

Alle ansehen

Idexx Laboratories Inc Aktie (IDXX) Neueste Nachrichten

04:53 AM

IDEXX launches first dual-species point-of-care NT-proBNP test for cardiac disease in cats and dogs - DVM360

04:53 AM

11:42 AM

Rationale Behind Baron Focused Growth Fund’s IDEXX Laboratories (IDXX) Holding - Yahoo Finance

11:42 AM

04:26 AM

Flossbach Von Storch SE Invests $9.09 Million in IDEXX Laboratories, Inc. $IDXX - MarketBeat

04:26 AM

04:12 AM

Danske Bank A S Buys New Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat

04:12 AM

Aug 19, 2026

Resilient IDEXX Laboratories stock trades in the mid-$550s as investors weigh premium valuation and - Ad-hoc-news.de

Aug 19, 2026

Aug 18, 2026

IDXX (IDEXX Laboratories) Cash Flow from Operations : $1,372 Mil (TTM As of Jun. 2026) - GuruFocus

Aug 18, 2026

IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch

Aug 18, 2026

IDEXX Laboratories stock holds above the mid-$540s as valuation stays demanding - Ad-hoc-news.de

Aug 18, 2026

IDXX (IDEXX Laboratories) Cash From Discontinued Investing Activities : $0 Mil (TTM As of Jun. 2026) - GuruFocus

Aug 18, 2026

Tranche Update on IDEXX Laboratories, Inc.'s Equity Buyback Plan announced on August 13, 1999. - marketscreener.com

Aug 18, 2026

Plato Investment Management Ltd Takes $1.48 Million Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat

Aug 18, 2026

IDEXX Labs Executing, But Valuation Continues To Weigh On That Execution (NASDAQ:IDXX) - Seeking Alpha

Aug 18, 2026

Aug 17, 2026

Weekly Recap: AI diagnostics expansion and Barclays trims target to $710 - TradingView

Aug 17, 2026